Cardiogen

Overview

Cardiogen is a research peptide conceptually related to Thymosin Beta-4 (TB-4), a naturally occurring thymic peptide known for its tissue repair and regenerative properties. In laboratory settings, Cardiogen is investigated for its potential to support cardiac muscle regeneration, enhance angiogenesis (formation of new blood vessels), and modulate inflammation in cardiovascular research models such as laboratory rodents.

Benefits

Recent preclinical research suggests that TB-4 analogs like Cardiogen may help promote repair of damaged heart tissue, improve cardiac function after myocardial injury, and stimulate new blood vessel growth in test subjects. Researchers are exploring Cardiogen’s impact on cardiac wound healing, fibrosis reduction, and overall heart muscle recovery following stress or damage.
Source: Bock-Marquette I, et al. Thymosin beta-4 activates integrin-linked kinase and promotes cardiac cell migration, survival, and cardiac repair. Circulation Research, 2020.

Possible Side Effects

In laboratory studies, test subjects administered Cardiogen (TB-4 analogs) may display mild side effects such as local injection site irritation, slight fluid retention, or mild immune modulation effects depending on dosage, test species, and study duration.
Source: Bock-Marquette I, et al., Circulation Research, 2020.

Dosage & Administration

Cardiogen is typically administered via subcutaneous or intramuscular injection following approved laboratory research protocols. Typical research dosages range from 1 mg to 5 mg per administration, delivered daily or multiple times per week depending on the study’s goals, species, and duration.
For laboratory research use only. Not for human consumption.

Summary

Cardiogen is a synthetic research peptide related to Thymosin Beta-4, developed exclusively for laboratory studies investigating cardiac muscle repair, angiogenesis, and post-injury heart tissue regeneration in preclinical models. Research suggests it may help improve heart function and reduce cardiac tissue damage with mild side effects such as injection site irritation occasionally noted in test subjects. Cardiogen is administered by subcutaneous or intramuscular injection, with dosage and frequency adjusted for each study’s design and species.
Strictly for research purposes only. Not for human use.